BACKGROUND: Southern Africa is witnessing the emergence of an epidemic of long-term survivors of vertically acquired human immunodeficiency virus (HIV) infection presenting with untreated HIV as adolescents. Dermatologic conditions, common in both HIV-infected adults and children, have not been described in this age-group. We investigated the prevalence and spectrum of skin conditions in adolescents admitted to hospitals in Zimbabwe. METHODS: A total of 301 consecutive adolescents admitted to 2 central Harare hospitals, underwent a dermatologic examination. Clinical history, HIV serology, and CD4 lymphocyte counts were obtained. Herpes simplex virus-2 serology was used as a surrogate marker for sexual activity. RESULTS: : A total of 139 (46%) patients were HIV-1 antibody positive, of whom only 2 (1.4%) were herpes simplex virus-2 antibody positive. The prevalence of any skin complaint among HIV-infected and uninfected participants was 88% and 14%, respectively (odds ratio: 37.7, 95% confidence interval: 19.4-72). The most common HIV-related conditions were pruritic papular eruptions (42%) and plane warts >5% of body area (24%). Having 3 or more skin conditions, a history of recurrent skin rashes and angular cheilitis were each associated with CD4 counts <200 cells/microL (P < 0.03, P < 0.01, and P < 0.05, respectively). CONCLUSIONS: Skin disease was a common and striking feature of underlying HIV-infection in hospitalized HIV-infected adolescents in Zimbabwe. In resource-poor settings with maturing epidemics, the presence of skin disease should be regarded as a strong indication for HIV testing and especially as it may reflect advanced immunosuppression. The high frequency of multiple plane warts has not previously been described, and may be a feature that distinguishes vertically-infected from horizontally-infected adolescents.
BACKGROUND: Southern Africa is witnessing the emergence of an epidemic of long-term survivors of vertically acquired human immunodeficiency virus (HIV) infection presenting with untreated HIV as adolescents. Dermatologic conditions, common in both HIV-infected adults and children, have not been described in this age-group. We investigated the prevalence and spectrum of skin conditions in adolescents admitted to hospitals in Zimbabwe. METHODS: A total of 301 consecutive adolescents admitted to 2 central Harare hospitals, underwent a dermatologic examination. Clinical history, HIV serology, and CD4 lymphocyte counts were obtained. Herpes simplex virus-2 serology was used as a surrogate marker for sexual activity. RESULTS: : A total of 139 (46%) patients were HIV-1 antibody positive, of whom only 2 (1.4%) were herpes simplex virus-2 antibody positive. The prevalence of any skin complaint among HIV-infected and uninfected participants was 88% and 14%, respectively (odds ratio: 37.7, 95% confidence interval: 19.4-72). The most common HIV-related conditions were pruritic papular eruptions (42%) and plane warts >5% of body area (24%). Having 3 or more skin conditions, a history of recurrent skin rashes and angular cheilitis were each associated with CD4 counts <200 cells/microL (P < 0.03, P < 0.01, and P < 0.05, respectively). CONCLUSIONS:Skin disease was a common and striking feature of underlying HIV-infection in hospitalized HIV-infected adolescents in Zimbabwe. In resource-poor settings with maturing epidemics, the presence of skin disease should be regarded as a strong indication for HIV testing and especially as it may reflect advanced immunosuppression. The high frequency of multiple plane warts has not previously been described, and may be a feature that distinguishes vertically-infected from horizontally-infected adolescents.
Authors: Jack S Resneck; Marta Van Beek; Lisa Furmanski; Jessica Oyugi; Philip E LeBoit; Elly Katabira; Fred Kambugu; Toby Maurer; Tim Berger; Mark J Pletcher; Edward L Machtinger Journal: JAMA Date: 2004-12-01 Impact factor: 56.272
Authors: A Obasi; F Mosha; M Quigley; Z Sekirassa; T Gibbs; K Munguti; J Todd; H Grosskurth; P Mayaud; J Changalucha; D Brown; D Mabey; R Hayes Journal: J Infect Dis Date: 1999-01 Impact factor: 5.226
Authors: S R Desai; S J Copley; R D Barker; C M Elston; R F Miller; A U Wells; S Munyati; K Nathoo; E L Corbett; R A Ferrand Journal: Clin Radiol Date: 2010-12-23 Impact factor: 2.350
Authors: S M Lowe; L Katsidzira; R Meys; J C Sterling; M de Koning; W Quint; K Nathoo; S Munyati; C E Ndhlovu; J R Salisbury; C B Bunker; E L Corbett; R F Miller; R A Ferrand Journal: Clin Infect Dis Date: 2012-04-03 Impact factor: 9.079
Authors: Tsitsi Bandason; Lisa F Langhaug; Memory Makamba; Sue Laver; Karin Hatzold; Stephen Mahere; Shungu Munyati; Stanley Mungofa; Elizabeth L Corbett; Rashida A Ferrand Journal: AIDS Care Date: 2013-03-26
Authors: Leandro S Linhar; Jefferson Traebert; Dayani Galato; Rosemeri M da Silva; Fabiana Schuelter-Trevisol; Natália S Rovaris; Jane da Silva Journal: Allergy Asthma Clin Immunol Date: 2014-07-07 Impact factor: 3.406